secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001213900-25-038427
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech issues 2.6M shares to Kepos in warrant exercise and downside settlement
--------------------------------------------------------------------------------

- Kepos exercised 555,555 warrants on a cashless basis, receiving 555,555 shares of NKGen common stock.
- In lieu of $509,555 cash downside consideration, Kepos accepted 2,038,220 shares at $0.25/share; 2,593,775 total shares issued.
- Outstanding $382,222 downside cash from prior reset to be satisfied with 1,528,888 shares at $0.25/share (future issuance).
- Shares are unregistered, bear restrictive legends, and may only be transferred under Rule 144 or other registration exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/0001213900-25-038427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390025038427/ea0239780-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-038427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer